TY - JOUR T1 - Acute Tubulointerstitial Nephritis in an HLA-B27-positive Patient With Axial Spondyloarthritis Being Treated With Adalimumab JO - Reumatología Clínica (English Edition) T2 - AU - Castro Corredor,David AU - Sánchez de la Nieta,María Dolores AU - de Lara Simón,Isabel María SN - 21735743 M3 - 10.1016/j.reumae.2017.03.011 DO - 10.1016/j.reumae.2017.03.011 UR - https://www.reumatologiaclinica.org/en-acute-tubulointerstitial-nephritis-in-an-articulo-S2173574318301072 AB - Antagonists of tumour necrosis factor-alpha (ATNF) are used for the treatment of multiple diseases such as psoriatic arthritis, Crohn's disease, ankylosing spondylitis and juvenile idiopathic arthritis, usually, when they are refractory to first-line treatment.1 The use of ATNF has been associated with the induction of autoimmune diseases such as systemic lupus erythematosus-like disease, vasculitis, sarcoidosis-like diseases and, recently, acute granulomatous tubulointerstitial nephritis. We report a case of acute nongranulomatous tubulointerstitial nephritis in an HLA-B27-positive patient with axial spondyloarthritis and Crohn's disease being treated with adalimumab. ER -